MUNICH, Germany , Oct. 19, 2017 -- At AWE Europe this week, Augumenta, Ltd. announced release of two software solutions that bring the power of Augmented Reality (AR) to Industry 4.0 deployments. They are:
- Augumenta Studio, a cloud-based tool that allows developers to quickly design AR applications for smartglass-equipped workers, and
- Augumenta SmartPanel, a customizable virtual control panel for industrial machinery operators.
With release of both solutions to the app stores of two leading makers of binocular smartglasses, Epson, Inc. and ODG, Inc., Augumenta is driving development of a platform independent ecosystem for industrial AR applications. Augumenta is also demonstrating its SmartAlert application, which empowers industrial workers to monitor and control machinery and plant operations using monocular smartglasses from such companies as Vuzix. An additional demonstration at the exhibition features a smartglass-enabled airplane fueling system recently announced by Liquid Controls.
“It’s very exciting to roll-out our platform for industrial AR and to show applications designed for specific commercial applications this year at AWE Europe,” said Tero Aaltonen, co-founder and CEO of Augumenta. “Applications like FlightConnect Glass which we co-developed with Liquid Controls show that AR is ready for roll-out in vertical markets. Concurrently, we are able to show the results of ongoing pilots with Siemens in the application of SmartPanel technology in shop floor environments.”
Augumenta Studio, which was a finalist for the HERMES AWARD 2017 presented earlier this year by Hannover Messe, is a platform that allows organizations to build glass applications using a drag-and-drop methodology. It is used by Augumenta and its customers to design and customize applications using SmartPanel and SmartAlert templates. Applications are easy to deploy to glass devices and support for industrial machine communication protocols ensures complete integration with in-place systems.
Augumenta is demonstrating its application suite and customer solutions at AWE Europe (Booth 219). More information is available at www.augumenta.com
About Augumenta
Augumenta supplies augmented reality applications and development tools to organizations that use smartglasses. The company’s software enables new ways for smartglass users to monitor and control machine operations and interact with Internet of Things (IoT) devices. Headquartered in Oulu, Finland, with a support hub in Taipei, Taiwan, Augumenta licenses its products to global OEMs, enterprise customers, integrators and developers. More than 200 companies have engaged with Augumenta to improve their bottom lines. More information and registration for the company newsletter is at www.augumenta.com.
Contacts:
Tero Aaltonen
[email protected]
+358 8 4154 1303
Augumenta, Ltd.
Matthew Schmidt
[email protected]
+1 650-345-3549
Small Planet Public Relations


Citigroup to Exit Russia With Sale of AO Citibank to Renaissance Capital
Elon Musk’s xAI Expands Supercomputer Infrastructure With Third Data Center to Boost AI Training Power
Neuralink Plans Automated Brain Implant Surgeries and Mass Production by 2026
Anghami Stock Soars After Strong H1 2025 Results, Revenue Nearly Doubles on OSN+ Integration
Lockheed Martin Secures Nearly $500 Million in U.S. and Allied Defense Contracts
Samsung Signals Comeback With HBM4 Chips as AI Market Heats Up
Hyundai Faces Deadline on Russia Plant Buyback Amid Ukraine War and Sanctions
ByteDance Plans Massive AI Chip Spending Boost as Nvidia Demand Grows in China
Target Stock Rallies as Activist Interest Sparks Hopes for Strategic Change
Disney Agrees to $10 Million Settlement Over Child Privacy Violations on YouTube
Nike Stock Rises After CEO Elliott Hill Buys $1 Million in Shares
SoftBank Completes $41 Billion OpenAI Investment in Historic AI Funding Round
Novo Nordisk and Eli Lilly Cut Obesity Drug Prices in China, Boosting Access to Wegovy and Mounjaro
Boeing Secures $8.6 Billion Pentagon Contract for F-15 Jets for Israel
Vanda Pharmaceuticals Wins FDA Approval for New Motion Sickness Drug After Four Decades 



